Developing best-in-class precision gene editing platforms to improve the safety and efficacy of CRISPR therapeutics.
Red Tree Participation
Led seed round
Red Tree Board Member
Heath Lukatch, Ph.D. (board chairman)
Red Tree Board Observer
Jennifer Cochran, Ph.D.

Total Addressable Market
$10 billion+
Red Tree Board Member(s)
Red Tree Board Member
Heath Lukatch, Ph.D. (board chairman)
Red Tree Board Observer
Jennifer Cochran, Ph.D.
Red Tree Participation
Led seed round
Acrigen Biosciences
Platform/Neurology
Total Addressable Market
$10 billion+
Red Tree Board Member(s)
Red Tree Board Member
Heath Lukatch, Ph.D. (board chairman)
Red Tree Board Observer
Jennifer Cochran, Ph.D.
Red Tree Participation
Led seed round